María Muñoz García-Borruel's research while affiliated with Hospital Universitario Virgen Macarena and other places

What is this page?


This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.

It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.

If you're a ResearchGate member, you can follow this page to keep up with this author's work.

If you are this author, and you don't want us to display this page anymore, please let us know.

Publications (11)


Role of Endoscopic Ultrasound and Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Treatment of Pancreatic Tumors
  • Chapter

April 2023

·

4 Reads

María Muñoz García-Borruel

·

·

Estefanía Moreno Rincón

·

Pancreatic cancer remains one of the most lethal malignancies in the world. Most patients diagnosed with pancreatic cancer present at an advanced stage of the disease. Therefore, early diagnosis and accurate staging are essential in the management of these patients. Cross-sectional imaging techniques and interventional endoscopies such as endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) play an important role in the initial evaluation, staging, and treatment of pancreatic lesions. Progressive biliary obstruction is often expected in pancreatic cancer, which could result in cholangitis, cholestasis, pruritus, liver failure, and premature mortality. Endoscopy-guided biliary decompression (ERCP and EUS) in resectable and unresectable tumors has gained more ground by replacing percutaneous drainage and surgery as the first approach. The main advantage of EUS over ERCP sampling is the possibility of obtaining a tissue diagnosis by performing fine needle aspiration biopsy (EUS-FNA), however, ERCP-guided biliary sampling could be performed first if a concurrent biliary decompression is required. Contrast-enhanced EUS and elastography are ancillary techniques that could be useful in clinical practice. Moreover, there are emerging EUS-guided therapeutic techniques that play an essential role in the management of pancreatic cancer.KeywordsPancreatic cancerEndoscopic ultrasoundEndoscopic ultrasound-guide fine needle aspirationEndoscopic retrograde cholangiopancreatographyBiliary drainage

Share


Post-colonoscopy colorectal cancer: Characteristics and predictive factors

November 2017

·

13 Reads

·

6 Citations

Medicina Clínica (English Edition)

María Muñoz García-Borruel

·

Antonio José Hervás Molina

·

·

[...]

·

Carlos Villar Pastor

Introduction and aims A high quality colonoscopy is key in preventing colorectal cancer, but the risk of colorectal cancer (CRC) exists. The aims of the study were to investigate the incidence, characteristics and predictive factors of post-colonoscopy colorectal cancer (PCCRC). Material and method A retrospective and prospective observational study was designed. A population undergoing colonoscopy between 1-01-1997 and 31-12-2014 was included. We analyzed demographic variables, characteristics of the diagnostic colonoscopy of CRC, of the previous ones and the lesions found in them. To compare the PCCRC group versus the CRC group without previous colonoscopy, the Student's t-test and multiple logistic regression were used to determine predictive factors of PCCRC (SPSS® 15). The statistical significance was p < 0.05. Results A total of 56,984 colonoscopies, 1977 CRC and 132 patients (mean 70.8 years old, 56.8% male) with at least one colonoscopy in 10 years before were registered (PCCRC). Seventy and a half percent of the previous colonoscopies were completed and 63.7% had an adequate bowel preparation. Predictive factors of PCCRC were personal history of polyps (OR 35.01; 95% CI 11.1–110.8; p < 0.001), previous CRC (OR 176.64; 95% CI 51.5–606.1); p < 0.001), family history of CRC (OR 3.14; 95% CI 1.5–6.4); p = 0.002) and proximal CRC (OR 3.15; 95% CI 2.1–4.9; p < 0.001). Conclusions PCCRC rate in 10 years was 6.7%. An adequate follow-up and a high-quality colonoscopy could prevent PCCRC, especially in patients with risk factors.


Cáncer colorrectal poscolonoscopia: características y factores predictivos

June 2017

·

9 Reads

·

3 Citations

Medicina Clínica

Introduction and aims: A high quality colonoscopy is key in preventing colorectal cancer, but the risk of colorectal cancer (CRC) exists. The aims of the study were to investigate the incidence, characteristics and predictive factors of post-colonoscopy colorectal cancer (PCCRC). Material and method: A retrospective and prospective observational study was designed. A population undergoing colonoscopy between 1-01-1997 and 31-12-2014 was included. We analysed demographic variables, characteristics of the diagnostic colonoscopy of CRC, of the previous ones and the lesions found in them. To compare the PCCRC group versus the CRC group without previous colonoscopy, the Student's t-test and multiple logistic regression were used to determine predictive factors of PCCRC (SPSS(®) 15). The statistical significance was P<.05. Results: A total of 56,984 colonoscopies, 1,977 CRC and 132 patients (mean 70.8 years old, 56.8% male) with at least one colonoscopy in 10 years before were registered (PCCRC). Seventy and a half percent of the previous colonoscopies were completed and 63.7% had an adequate bowel preparation. Predictive factors of PCCRC were personal history of polyps (OR 35.01; 95% CI 11.1-110.8; P<.001), previous CRC (OR 176.64; 95% CI 51.5-606.1); P<.001), family history of CRC (OR 3.14; 95% CI 1.5-6.4); P=.002) and proximal CRC (OR 3.15; 95% CI 2.1-4.9; P<.001). Conclusions: PCCRC rate in 10 years was 6.7%. An adequate follow-up and a high-quality colonoscopy could prevent PCCRC, especially in patients with risk factors.


Table 1.  Main baseline characteristics of the study group.
Fig 1.  Probability of liver transplantation
Fig 2.  Exclusion rates of WL
Table 2.  Determinants of mortality on the waiting list: hepatic insufficiency group and refractory ascites group.
Fig 3.  Early mortality post-LT

+4

Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality
  • Article
  • Full-text available

June 2016

·

81 Reads

·

12 Citations

PLOS ONE

Background and aims: MELD allocation system has changed the clinical consequences on waiting list (WL) for LT, but its impact on mortality has been seldom studied. We aimed to assess the ability of MELD and other prognostic scores to predict mortality after LT. Methods: 301 consecutive patients enlisted for LT were included, and prioritized within WL by using the MELD-score according to: hepatic insufficiency (HI), refractory ascites (RA) and hepatocellular carcinoma (HCC). The analysis was performed to predict early mortality after LT (8 weeks). Results: Patients were enlisted as HI (44.9%), RA (19.3%) and HCC (35.9%). The major aetiologies of liver disease were HCV (45.5%). Ninety-four patients (31.3%) were excluded from WL, with no differences among the three groups (p = 0.23). The remaining 207 patients (68.7%) underwent LT, being HI the most frequent indication (42.5%). HI patients had the shortest length within WL (113.6 days vs 215.8 and 308.9 respectively; p<0.001), but the highest early post-LT mortality rates (18.2% vs 6.8% and 6.7% respectively; p<0.001). The independent predictors of early post-LT mortality in the HI group were higher bilirubin (OR = 1.08; p = 0.038), increased iMELD (OR = 1.06; p = 0.046) and non-alcoholic cirrhosis (OR = 4.13; p = 0.017). Among the prognostic scores the iMELD had the best predictive accuracy (AUC = 0.66), which was strengthened in non-alcoholic cirrhosis (AUC = 0.77). Conclusion: Patients enlisted due to HI had the highest early post-LT mortality rates despite of the shortest length within WL. The iMELD had the best accuracy to predict early post-LT mortality in patients with HI, and thus it may benefit the WL management.

Download




Colangiopancreatografía retrógrada endoscópica en pacientes con alteraciones de la anatomía gástrica por cambios posquirúrgicos

December 2013

·

10 Reads

·

1 Citation

Gastroenterología y Hepatología

Introduction In patients who have undergone partial gastric resections, the difficulty of performing endoscopic retrograde cholangiopancreatography (ERCP) is increased due to the resulting anatomic abnormality. Aim To review our experience of ERCP in patients with Billroth II gastrectomy and other types of gastrectomy (Billroth I and indeterminate) in our center. Material and methods We included all patients with Billroth II gastrectomy or other types of gastrectomy undergoing ERCP in a 19-year period. Results We included 233 patients (91% men and 9% women) from 1993 to 2012. A total of 88.4% of the patients had undergone Billroth II and 11.6% had undergone other types of gastrectomy, with an ERCP success rate of 51.9% and 55.6%, respectively. The most common causes of failure were inability to cannulate (44%) and failure to identify the papilla (39.6%). The final diagnosis was choledocholithiasis in 31.8%. The mean number of sessions was 1.09. The complications rate was 2.6%. Conclusions The success of ERCP is influenced by the technical difficulty. For this reason, the success rate in our center was slightly over 50%, but with few complications.


[Endoscopic retrograde cholangiopancreatography in patients with anatomic abnormalities of the stomach due to surgery.]

October 2013

·

12 Reads

·

3 Citations

Gastroenterología y Hepatología

In patients who have undergone partial gastric resections, the difficulty of performing endoscopic retrograde cholangiopancreatography (ERCP) is increased due to the resulting anatomic abnormality. To review our experience of ERCP in patients with Billroth II gastrectomy and other types of gastrectomy (Billroth I and indeterminate) in our center. We included all patients with Billroth II gastrectomy or other types of gastrectomy undergoing ERCP in a 19-year period. We included 233 patients (91% men and 9% women) from 1993 to 2012. A total of 88.4% of the patients had undergone Billroth II and 11.6% had undergone other types of gastrectomy, with an ERCP success rate of 51.9% and 55.6%, respectively. The most common causes of failure were inability to cannulate (44%) and failure to identify the papilla (39.6%). The final diagnosis was choledocholithiasis in 31.8%. The mean number of sessions was 1.09. The complications rate was 2.6%. The success of ERCP is influenced by the technical difficulty. For this reason, the success rate in our center was slightly over 50%, but with few complications.


Citations (5)


... 15 Differences in methodology used to calculate the PCCRC rate, with different time frames and inclusion or exclusion criteria, could explain these variations. 16 For example, in our study, we exclude high-risk populations, such as patients with IBD or hereditary nonpolyposis CRC, whereas these patients are often included in previous studies, [11][12][13][14][15] which could explain part of the differences. Furthermore, some studies were published before the WEO consensus and do not use a standardized and uniform method to calculate PCCRC. ...

Reference:

Incidence, characteristics, and predictive factors of post-colonoscopy colorectal cancer
Post-colonoscopy colorectal cancer: Characteristics and predictive factors
  • Citing Article
  • November 2017

Medicina Clínica (English Edition)

... We found that there is a statistically significant association between baseline serum AFP, tumour grade and microvascular invasion. Higher AFP values indicate greater degree of de-differentiation and angioinvasion [23]. Patients with baseline AFP level ≥ 400 ng/ml have approximately 4 times higher risk of pulmonary metastases [24]. ...

Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality

... This morphologic and immunophenotypic profile may be compared to that of a group of lesions that goes under the umbrella definition of "pseudosarcomatous myofibroblastic proliferations" (PMPs) [18][19][20][21][22]. PMPs are similar to nodular fasciitis in its various expressions (proliferative fasciitis, proliferative myositis, and ossificans) [19,21] and from time to time are labeled under various designations such as visceral fasciitis, pseudosarcomatous fibromyxoid tumor [19], spindle cell pseudomalignant proliferation, postoperative spindle cell nodule [23], and inflammatory pseudotumor [18]. These lesions most often occur in the genitourinary system (bladder, prostate, ureter, vagina, and vulva) [24][25][26] but can occasionally arise in the gastrointestinal tract [27,28] or in the organs of the upper aerodigestive tract (pharynx, larynx, nasal cavities, and mouth) [29,30]. They should be clearly distinguished from the inflammatory myofibroblastic tumor (IMT) [31,32], and for this reason the confusing adjective inflammatory should be avoided in their description. ...

Inflammatory pseudotumor of the liver: A propos of a case
  • Citing Article
  • April 2016

Gastroenterología y Hepatología (English Edition)

... This morphologic and immunophenotypic profile may be compared to that of a group of lesions that goes under the umbrella definition of "pseudosarcomatous myofibroblastic proliferations" (PMPs) [18][19][20][21][22]. PMPs are similar to nodular fasciitis in its various expressions (proliferative fasciitis, proliferative myositis, and ossificans) [19,21] and from time to time are labeled under various designations such as visceral fasciitis, pseudosarcomatous fibromyxoid tumor [19], spindle cell pseudomalignant proliferation, postoperative spindle cell nodule [23], and inflammatory pseudotumor [18]. These lesions most often occur in the genitourinary system (bladder, prostate, ureter, vagina, and vulva) [24][25][26] but can occasionally arise in the gastrointestinal tract [27,28] or in the organs of the upper aerodigestive tract (pharynx, larynx, nasal cavities, and mouth) [29,30]. They should be clearly distinguished from the inflammatory myofibroblastic tumor (IMT) [31,32], and for this reason the confusing adjective inflammatory should be avoided in their description. ...

[Inflammatory pseudotumor of the liver: A propos of a case]
  • Citing Article
  • August 2015

Gastroenterología y Hepatología

... [4] A 19-year review of ERCP in patients with altered gastrointestinal anatomy from a single center reported a successful duodenal intubation rate of 51.9%, with failure resulting from the inability to cannulate (44%) or to identify the papilla (39.6%). [8] Percutaneous transhepatic papillary balloon dilatation is an alternative interventional radiological procedure for these cases. The technique was first reported by Staritz et al [9] in 1983. ...

[Endoscopic retrograde cholangiopancreatography in patients with anatomic abnormalities of the stomach due to surgery.]
  • Citing Article
  • October 2013

Gastroenterología y Hepatología